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OBJECTIVES: To develop and validate the Geriatric
CompleXity of Care Index (GXI), a comorbidity index of
medical, geriatric, and psychosocial conditions that
addresses disease severity and intensity of ambulatory care
for older adults with chronic conditions.
DESIGN: Development phase: variable selection and rat-
ing by clinician panel. Validation phase: medical record
review and secondary data analysis.
SETTING: Assessing the Care of Vulnerable Elders-2
study.
PARTICIPANTS: Six hundred forty-four older (75)
individuals receiving ambulatory care.
MEASURES: Development: 32 conditions categorized
according to severity, resulting in 117 GXI variables. A
panel of clinicians rated each GXI variable with respect to
the added difficulty of providing primary care for an indi-
vidual with that condition. Validation: Modified versions
of previously validated comorbidity measures (simple
count, Charlson, Medicare Hierarchical Condition Cate-
gory), longitudinal clinical outcomes (functional decline,
survival), intensity of ambulatory care (primary, specialty
care visits, polypharmacy, number of eligible quality indi-
cators (NQI)) over 1 year of care.
RESULTS: The most-morbid individuals (according to
quintiles of GXI) had more visits (7.0 vs 3.7 primary care,
6.2 vs 2.4 specialist), polypharmacy (14.3% vs 0% had
14 medications), and greater NQI (33 vs 25) than the
least-morbid individuals. Of the four comorbidity mea-
sures, the GXI was the strongest predictor of primary care
visits, polypharmacy, and NQI (P < .001, controlling for
age, sex, function-based vulnerability).
CONCLUSION: Older adults with complex care needs, as
measured by the GXI, have healthcare needs above what
previously employed comorbidity measures captured.
Healthcare systems could use the GXI to identify the most
complex elderly adults and appropriately reimburse
primary providers caring for older adults with the most
complex care needs for providing additional visits and
coordination of care. J Am Geriatr Soc 61:542–550, 2013.
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The medical home has been hailed as a new system-based strategy for providing high-quality patient-
centered primary care,1 but one challenge that medical
homes face will be to provide high-quality care to the older
adults with the most complex care needs, typically those
with multiple chronic conditions.2 Individuals with multi-
morbidity are at greater risk for mortality and disability
than those with no major chronic conditions3,4 and gener-
ate greater healthcare costs.5,6 Beyond daily medication
and self-care routines, individuals with multimorbidity
have been described as having frequent pharmacy7 and
doctor visits8,9 and multiple prescribers.7 Recent research
has shifted attention to the potential burden of applying
individual chronic disease guidelines to individuals with
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multiple chronic diseases.10,11 For clinicians, prioritizing
patients’ multiple conditions is a critical source of com-
plexity.12 As health systems assume responsibility for
delivering high-quality care to defined populations of indi-
viduals, understanding the intensity of care required to
care for the older adults with the most-complex needs will
become critically important.
The current approach to measuring multimorbidity
and its effect on delivering high-quality care ignores geriat-
ric conditions and the severity of individual diseases.13,14
Geriatric conditions are prevalent in older adults15 and are
associated with functional decline15 and poor quality of
care.16 Therefore, as part of the Assessing the Care of Vul-
nerable Elders-2 (ACOVE-2)17 study, an effort was made
to develop a new, more-comprehensive comorbidity index
for older adults. The Geriatric CompleXity of Care Index
(GXI) includes difficult-to-manage geriatric conditions
(e.g., dementia and falls) and severity ratings for geriatric
and other chronic diseases. This article describes the devel-
opment and multistep validation of the GXI index
(Figure 1).
ACOVE-2 was an ideal opportunity to study comor-
bidity and complexity of care. Participants had geriatric
and other conditions and were evaluated for eligibility for
a comprehensive set of ambulatory care quality indicators
(QIs) as a measure of complexity of care. It was primarily
hypothesized that the GXI would be a better predictor of
complicated ambulatory care (number of eligible QIs and
polypharmacy) than three previously employed comorbidity
measures: a simple count of 12 conditions used in prior
ACOVE studies,13,18,19 the Charlson Comorbidity Index
(CCI),20 and Medicare Hierarchical Condition Categories
(HCC).5 The secondary hypotheses were that the CCI
would be the best at predicting clinical outcomes (function
and survival) and that the HCC would be the best at
predicting number of ambulatory care visits.
METHODS
Development of the GXI
First, candidate conditions were identified based on a
nosology of diseases of aging.21 Candidate conditions were
considered if they were chronic, symptomatic, and preva-
lent and required ambulatory care. Conditions were strati-
fied according to disease severity, including subclinical
forms (e.g., pre-diabetes mellitus (DM)), as less-severe ver-
sions of the conditions. When available, existing staging
methods were used (e.g., New York Heart Association
heart failure criteria22). In other cases, commonly docu-
mented symptoms were used as indicators of severity (e.g.,
behavior problems as a severity criterion for dementia).
Combinations of common co-prevalent conditions in older
adults were also considered as sources of additional com-
plexity: hypertension and chronic kidney disease (CKD);23
DM and CKD;23 and depression, insomnia, and anxi-
ety.24,25 In total, 146 candidate variables were considered
Figure 1. Development and validation of the Geriatric CompleXity of Care Index (GXI). NQI = number of quality indicators.
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(32 conditions, stratified according to severity, with poten-
tial interactions between conditions and levels of severity).
Expert panel assessment
A panel of six clinician–researchers (including LM, DR,
DG, PS, and NW) with experience in clinical care of
older adults with complex care needs, quality measure-
ment, and comorbidity was first convened. In two rounds
of voting, the panelists first voted on inclusion of candi-
date variables and then weighted each condition accord-
ing to their assessment of difficulty involved with caring
for an older adult with that condition over 1 year of pri-
mary care. Each candidate variable was rated on a scale
from 1 to 10, with higher scores representing a more-
complex form of the condition. Each GXI variable was
assigned the median rating of the six raters as the final
complexity weight. Two combinations of multiple condi-
tions (DM and CKD; depression, anxiety, and insomnia)
were rated as having more complexity than the sum of
the individual conditions. The panel’s final number of
GXI variables (conditions, severity levels, and interac-
tions) was 117 (Appendix 1).
Setting and data collection
Medical records from ACOVE-217, a practice-based inter-
vention in 2002 that enrolled 644 individuals at two multi-
site ambulatory care practices in southern California, were
reviewed. This cohort comprised older adults (75) who
had at least one of three geriatric conditions (urinary
incontinence (UI), impaired memory, and falls). Within
each practice, one site received a multicomponent practice-
directed quality improvement intervention26 for dementia,
falls, and UI; the other sites (one in the first practice, four
at the other) served as controls (only patient screening).
In the original ACOVE-2 study, participants’ complete
ambulatory medical records (including all primary and spe-
cialty care providers for the 13-month study) were collected
for evaluation of 98 ACOVE ambulatory care quality indi-
cators (QIs) in 13 areas of medical and geriatric care
(dementia, depression, DM, falls and fear of falling, hearing
impairment, hypertension, malnutrition, osteoporosis, osteo-
arthritis, pain, UI, medication use, screening and preven-
tion).27 A detailed medical record review was performed to
determine eligibility for 65 QIs. In addition, 578 partici-
pants were interviewed upon enrollment, which determined
eligibility for an additional 33 interview-based QIs.
For the current study, complete medical records were
re-abstracted for the 117 GXI variables during the study
year. Two abstractors (LM, AW) were blinded to which
QIs were previously measured.16,17,27 The mean time
needed to abstract a chart for the GXI was 12 minutes.
The institutional review boards at RAND Health and the
University of California at Los Angeles approved this
study.
Primary predictor variable: GXI comorbidity score
Each individual’s GXI score was calculated, based on his
or her conditions, as the sum of the complexity weights as
rated by the expert panel. A higher GXI indicated greater
burden. For example, if an individual had uncomplicated
atrial fibrillation (AF) (complexity weight = 3), uncompli-
cated emphysema (complexity weight = 4), and hypercho-
lesterolemia (complexity weight = 2), the GXI score was
calculated to be 9.
Outcome variables
To validate the GXI, six outcome measures of clinical
complexity were studied. These measures were not based
on medical conditions and included two clinical outcomes,
two provider visit variables, polypharmacy, and number of
eligible QIs.
Clinical outcomes
Longitudinal functional decline and mortality outcomes
had been previously collected on the ACOVE-2 cohort
(2002–2007).28 Functional decline was defined using the
Short Functional Survey (SES),29,30 which summarizes
independence in five activities of daily living (shopping,
light housework, finances, bathing, and walking; 0–5 pos-
sible points). Two 5-year outcomes were calculated for
each individual: death versus survival and functional
decline versus no decline. Full information was available
on death outcomes. Information on functional decline
outcomes was collected for 295 participants.
Primary care provider and specialty care visits
As a measure of ambulatory care use, available administra-
tive data were used to identify the number of visits to the
individual’s primary care provider. If more visits were
made to an alternate primary care provider, the alternate
provider was assigned as the individual’s primary care pro-
vider. Each individual’s specialty visits over the same time
period were counted.
Number of eligible quality indicators
Because each ACOVE ambulatory care QI specifies an
individual’s eligibility for an ambulatory care process,31 it
was determined that the number of eligible QIs (NQI) for
each individual could serve as a unique marker of the clin-
ical care needed to meet quality standards.
The number of medical-record based ambulatory care
QIs for which each individual was eligible (of 65 possible)
was calculated for each individual. For participants who
provided interview-based eligibility information, an alter-
native NQI was calculated that combined medical record
and interview eligibility methods (98 QIs possible). As in
the original ACOVE-2 study, individuals with advanced
dementia and limited life expectancy were not eligible for
a subset of QIs based on appropriateness criteria.32
Because nearly all QIs require more care (only 2 of 98
were “overuse”-type QIs), a higher NQI indicates an indi-
vidual needing higher-intensity ambulatory care.
Medication use
As an additional measure of ambulatory care intensity,7 the
maximum number of medications documented in the medical
record at any visit was counted. Only prescribed medications
or over-the-counter medications recommended on a long-
term basis for chronic condition management were included.
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Polypharmacy was categorized as none (6 medications),
mild (6–8), moderate (9–12), or severe ( 14).
Comparison comorbidity measures (simple count,
CCI, and HCC)
The ACOVE simple count consisted of 12 conditions: AF,
coronary artery disease, heart failure, cerebrovascular
disease, DM, hypertension, dementia, falls, hearing impair-
ment, UI, malnutrition, and osteoporosis (starred in
Appendix 1).
All 19 comorbidities from the CCI20 were mapped to
GXI variables to calculate a modified CCI score (mCCI)
for each individual. Claims data necessary to calculate the
HCC directly (based on 80 acute and chronic conditions)
were not available. To calculate a modified HCC score
(mHCC), 37 ambulatory care conditions were mapped to
the HCC, and previously published community-based
weights were applied. Five for mCCI and mHCC, points
were omitted for age and sex because these variables are
not included in the GXI and simple count.
Covariables
Sex, age, ACOVE-2 intervention site, and the Vulnerable
Elders Survey-13 (VES-13) were used in multivariable
models.33 The VES-13 is a 13-item screening tool (11
items pertaining to physical abilities and activities of daily
living, 1 item regarding self-rated health, and age) that
predicts death and further functional decline. It contains
no comorbidity variables and predicts outcomes indepen-
dently of comorbidity.28,33,34
Analysis
To validate the GXI (Figure 1), first 10 comorbidity vign-
ettes of ACOVE-2 participants were reviewed for face valid-
ity, then the GXI was correlated with previously validated
comorbidity measures for construct validity (simple count,
mHCC, and mCCI), and finally the GXI was analyzed
against external (noncomorbidity) measures for convergent
(predictive) validity and its performance was compared with
the previously validated comorbidity measures.
Qualitative review of 10 multimorbid individuals
receiving ambulatory care
To review for face validity, ACOVE-2 participants with
increasing combinations of five conditions (hypertension,
coronary artery disease, DM, AF, and dementia) were
selected, a method based on prior comorbidity work.19 All
individuals with none of the five conditions were identified
as the first tier, those with hypertension and none of the
remaining conditions as the second tier, and so on, up to
individuals with all five conditions for the sixth tier. Two
individuals were selected from each tier, one with a low
(bottom tertile) GXI score, and one with a high (top
tertile) GXI score, for qualitative review as comorbidity
vignettes (Appendix 2).
Quantitative analysis
Correlations were first calculated between the GXI and the
previously validated comorbidity measures. Next, to
validate the GXI against the noncomorbidity measures,
unadjusted effect (logistic and linear regression) was calcu-
lated on clinical outcomes, ambulatory care visits, and
complexity of care measures for increasing quintiles of
GXI scores (Table 2). Multivariable regression was used to
introduce control variables (age, sex, VES-13, intervention
site) and to calculate the effect of GXI (top minus bottom
quintile, last columns of Table 2) on the external valida-
tion variables.
To compare how well the GXI predicted the external
validation measures with the previously validated comor-
bidity variables, each comorbidity measure was paired
with each external outcome using model fit (coefficient of
determination; R2 for linear regression models and area
under the receiver operating characteristic curve (AUC) for
logistic models) as the comparative metric (Table 3). Last,
GXI and each previously validated comorbidity index was
entered into fully adjusted models using tests of statistical
independence (P < .05) to evaluate whether the more-
resource-intensive GXI score would better predict the out-
comes than the previously validated comorbidity variables.
All analyses were performed using Stata 12 (Stata Corp.,
College Station, TX).
RESULTS
Clinician panel ratings for 117 GXI comorbidity
variables (Appendix 1; online version only)
The range of median ratings by the panel extended from
1 (history of smoking in a nonsmoker) to 8 (severe liver
disease, new depression with symptoms of insomnia and
anxiety, nonsevere dementia with behavior problems, and
severe dementia with behavior problems).
Qualitative review of 10 comorbidity vignettes
(Appendix 2; online version only)
Review of the vignettes confirmed that, within similar con-
ditions, individuals selected for high complexity scores
were substantively more complex in the nature of their
conditions, medication regimens, and NQI and had more
doctor visits.
As an example of how GXI distinguished clinical
complexity, two individuals were identified as having
hypertension but none of the four other conditions (coro-
nary artery disease, DM, AF, and dementia; Tier 2,
Appendix 2). Although one did not have complex care
needs (2nd percentile on GXI score) and the other did
(80th percentile), both had a simple condition count of 3.
The noncomplex individual had well-controlled hyperten-
sion (2 points added to GXI), normal weight (0 points),
osteoporosis without fracture (2 points), hearing impair-
ment (2 points), and falls (5 points). By contrast, the
complex individual’s hypertension was moderately severe
(3 points), and she had chronic pain (5 points), hypothy-
roidism (2 points), hearing (2 points) and vision problems
(3 points), fatigue (5 points), insomnia (2 points), and
stable mild kidney disease (2 points). She developed a
new osteoporotic fracture (6 points), weight loss (4
points), new anemia (2 points), and new UI (4 points).
Despite the vast difference in complexity, the simple
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condition count did not indicate a difference in complex-
ity between these two individuals.
Quantitative results
Sample characteristics are described in Table 1.
The GXI was correlated with all of the previously
validated comorbidity scores (P < .001): simple count
(r = .66), mCCI (r = .62), and mHCC (r = .73).
The GXI defined increasing care intensity, with sub-
stantial and statistically significant tests of trends across all
of the unadjusted intensity variables (P < .001 for all
except functional decline, P < .02) (Table 2). An individ-
ual in the top quintile of GXI, on average, visited her
primary care provider 7.0 times, versus 3.7 times for an
individual in the bottom quintile. No individuals in the
healthiest quintile had the most-severe category of poly-
pharmacy, but 14% of those in the highest quintile were
in this category. The mean NQI was 16 for the most com-
plex quintile and 9 for the least complex. Although the
GXI was associated with functional decline and survival
on bivariate analysis, it was not as strong as the VES-13 in
the multivariable model (last column, Table 2) and became
nonsignificant in adjusted models.
When comparing the GXI with the other comorbidity
variables at predicting outcomes (using model fit as the cri-
terion), the GXI was comparable with or worse than pre-
viously validated indices for predicting death and decline
but better at predicting care intensity: doctor visits, poly-
pharmacy, and NQI (defined as an R2 or AUC of >5%
points better than at least one other index, Table 3), with
polypharmacy reaching the excellent AUC range (>0.8).
The GXI also independently (P < .01) predicted primary
care and specialty visits, polypharmacy, and NQI, control-
ling for age, sex, intervention site, and VES-13 and when
any of the three previously validated comorbidity measures
(simple count, mCCI, mHCC) was also entered into the
model (not shown). The mHCC was the best predictor
(P < .001, even with any other three comorbidity variables
included) of death. None of the comorbidity variables pre-
dicted 5-year functional decline independent of VES-13
(odds ratio = 2.0 per point, P < .001 for all models).
DISCUSSION
This article describes the multistage development of a com-
prehensive measure of geriatric comorbidity, the GXI. The
GXI predicted ambulatory care intensity, as measured
according to primary and specialty care visits, poly-
pharmacy, and eligibility for complex ambulatory care
processes independent of age, functional status, and previ-
ously validated measures of comorbidity. The GXI
captured complex care as measured according to NQI and
complexity of medication management well. The authors
believe that they were successful at capturing ambulatory
care intensity with the GXI because geriatric conditions
and severity of disease were considered.
In contrast with other comorbidity studies,5,6,12,20 the
GXI was also tested against functional status, an impor-
tant outcome for older adults. Functional impairment has
also been included as a condition in other comorbidity
indices.35,36 Although comorbidity and function are
Table 1. Sample Characteristics
Characteristic Value
Demographic
Age, mean  SD (range) 81.2  4.8 (75–100)
Male, n (%) 217 (33.6)
Clinical
Vulnerable Elders Survey-13 score,
mean  SD (range)a
4.6  2.9 (1–9)
Number of activity of daily living
impairments, mean  SD
(range)b
0.9  1.44 (0–5)
Simple count of conditions,
mean  SD (range)c
3.6  1.6 (0–9)
Modified Charlson Comorbidity
Index, mean  SD (range)d,20
3.7  2.6 (0–11)
Modified Hierarchical Condition
Count score (predicted annual
cost), $, mean  SD (range)e
7,432  4,665 (2,475–30,125)
Geriatric Complexity of Care score,
mean  SD (range)
31.3  11.6 (7–72)
Health care
Number of visits with assigned
primary care provider,
mean  SD (range)
5.4 3.3 (0–20)
Number of visits with specialists,
mean  SD (range)
3.9 5.6 (0–62)
Polypharmacy (number of chronic medications), n (%)
None ( 6) 316 (49)
Moderate (7–9) 172 (26.8)
Severe (10–13) 117 (18.2)
Very severe ( 14) 39 (6.1)
NQI needed (as documented in
medical record), mean  SD
(range)
12.2  4.3 (3–26)
NQI (as documented in medical
record and in interviews),
mean  SD (range)f
27.5  6.8 (8–47)
The analytical sample is from the Assessing the Care of Vulnerable Elders-
2 Study,17 which originally screened 2,671 individuals aged  75 for falls,
urinary incontinence (UI), and memory impairment; 784 of these (29%)
screened positive for one or more of the geriatric conditions, and 649
(83%) agreed to enroll in the study. Adequate medical records were
obtained for 644 (99%) to review for quality and complexity of care. The
longitudinal outcomes of the overall sample have been previously
reported:28 220 (34%) of the sample died. Two hundred ninety-five of the
survivors were contacted for a functional status interview 5 years after
enrollment.
a A function-based risk score predicting 1-, 2-, and 5-year risk of func-
tional decline or death.28,33,34 A score of  3 identifies individuals aged
65 or higher at the 30% highest risk.
b Number of self-reported disabilities of 5 possible (shopping, light house-
work, walking, bathing, finances) reported as difficult and requiring help
or not doing because of health according to the Short Functional Survey.29
c Unweighted sum of atrial fibrillation, coronary artery disease, congestive
heart failure, cerebrovascular disease, diabetes mellitus type 2,
hypertension, dementia, falls, hearing impairment, UI, malnutrition, and
osteoporosis.
d Charlson Comorbidity Index20 was calculated without age and sex
points, using comorbidities only, analogous to the simple count and Geri-
atric CompleXity of Care Index score.
e Comorbidity using dollar weights from the Medicare Hierarchical Condi-
tion Category5 score. The modified HCC did not include acute diseases,
age, and sex weights.
f The n for these variables was 578 who participated in the quality-of-care
interview.
SD = standard deviation; NQI = number of quality indicators.
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Table 3. Comparison Between the Geriatric CompleXity of Care Index (GXI) and Previously Validated Comorbid-
ity Indexes in Predicting Clinical and Healthcare Outcomes
Outcome
Simple Count mCCI mHCC GXI Simple Count mCCI mHCC GXI
Unadjusted (%) Adjusted (%)
Continuous outcomes (R2)
Primary clinician visits 6.1 3.6 5.9 13.6a 6.4 3.8 6.1 14.3a
Specialty visits 2.5 2.0 9.1 8.2 4.0 2.9 9.9 9.1a
NQI (medical record only) 33.2 17.7 14.3 30.5a 35.2 19.6 15.8 32.8a
NQI (interview and medical record) 14.2 5.3 5.6 18.1a 24.8 17.5 16.6 30.6a
Dichotomous outcomes (AUC)
5-year mortality 64.7 67.9 69.1 61.8 77.1 77.5 78.7 76.2
5-year functional decline 51.7 61.4 56.8 56.3 89.6 89.9 89.6 83.8
Polypharmacy ( 14 medications) 72.2 59.7 73.9 78.0a 76.2 70.1 76.9 81.5a
Adjusted models controlled for age, sex, vulnerability, and intervention versus control site.
a GXI R2 or area under the receiver operating characteristic curve (AUC) at least 5 percentage points better than any one of the previously validated
comorbidity indices.
mCCI = modified Charlson Comorbidity Index,20 risk of death calculated without age; GXI = Geriatric CompleXity of Care Index; mHCC = modified
Medicare-Hierarchical Condition Category,5 predicted annual cost for community-based sample, calculated without acute diseases, age, and sex;
NQI = number of quality indicators.
Table 2. Mean Clinical and Intensity-of-Care Variables Across Quintiles of Geriatric CompleXity of Care Index
(GXI) in Assessing Care of Vulnerable Elders 2
Variable
Mean (Unadjusted) Values Across Quintiles of GXI (Range of GXI Points






















0.3 0.7 1.2 1.1 1.3 <.001 0.8 (0.5 to 1.1)
VES-13 score at
baseline (range 0–10,
higher = greater risk)c
3.1 3.9 5.1 5.2 5.6 <.001 2.0 (1.6 to 2.5)
Died (5-year),% 21.5 23.2 36.4 42.5 45.1 <.001 4.8 (0 to 14)
Functional decline
(5-year),%d
4.5 4.1 11.1 11.5 14.3 .02 2.5 (2.4 to 3.1)
Primary care visits, n 3.7 4.5 5.5 6.2 7.0 <.001 3.5 (2.7 to 4.3)
Specialty visits, n 2.4 2.6 3.8 4.3 6.2 <.001 3.8 (2.8 to 5.7)
 14 chronic
medications,%e




9.2 10.4 12.0 13.0 15.9 <.001 7.1 (6.1 to 8.4)
All QIs eligible from
medical record and
interview, n (n = 578)f
23.5 26.0 27.4 28.5 31.9 <.001 9.7 (8.0 to 11.3)
a Predicted outcomes for top versus bottom quintile of GXI, controlling for age, sex, Vulnerable Elders Survey-13 (VES-13), and intervention group. GXI
was a five-category variable. Confidence intervals were obtained using bootstrapping. VES-13 was omitted as a control variable to predict VES-13 and
activity of daily living disabilities because of colinearity.
b Functional status as measured according to the Short Functional Survey (SFS).29
c A scale predicting risk of 1-34, 2-33, and 534-year risk of functional decline and death.
d Five-year functional decline was defined as SFS decline of  1 abilities.29,30 Two hundred ninety-five survivors participated in the follow-up SFS. The
reduced quintile sample sizes for the 5-year functional decline outcome was (1st through 5th): 66, 74, 54, 52, 59.
e Includes routine prescriptions for chronic conditions, “as needed” if taken on more than half of days, and nutritional supplements for management of
chronic conditions.
f Based on a sample size of 578, the number interviewed. The reduced quintile sample sizes were (1 through 5): 99, 124, 120, 120, 115.
QI = quality improvement.
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important health concerns for older adults, by keeping them
separate, it was possible to evaluate their relative contribu-
tions to the various outcomes tested. As an example, the
GXI was independent of the VES-13, the function-based
covariable, at predicting NQI, but GXI was less predictive
than VES-13 at predicting future decline. This is consistent
with prior work, in which it was found that the VES-13 was
an effective and parsimonious way to predict clinical
outcomes in older community-dwelling adults and that
comorbidity added no predictive value.33,34
Unlike other comorbidity measures that give more
weight to acute medical and surgical conditions to predict
death20 and cost,5,6 the current study gave greater weight
to the more difficult-to-manage geriatric conditions from
the perspective of primary care clinicians. Therefore, the
GXI complements the other indices by focusing on a dif-
ferent, but important, area of care—ambulatory care of
older adults with multiple chronic conditions. In this
study, the GXI was the best predictor of number of visits
a primary care clinician will need to provide in a given
year based on the complexity of his or her patients or a
way to target valuable medical home resources for individ-
uals with more-complex needs, such as pharmacy review
or added care coordination.
The GXI was not as good as the other indices at pre-
dicting survival or functional decline, underscoring prior
findings that no comorbidity index can predict all out-
comes for all individuals.37 The mHCC, originally derived5
to adjust for high-cost individuals, was the best predictor
of survival in this sample, even though not all of the acute
illness variables necessary to compute a full score were
available. It is not surprising that cost and mortality would
be closely related, given accelerated costs at the end of
life.38,39 The results suggest that the mHCC would be a
more-efficient way to risk-adjust for death outcomes than
the GXI. Additionally, the mHCC outperformed the GXI
at predicting specialty visits, consistent with the known
relationship between mHCC and higher-cost care.
This study highlights the value of NQI, which quanti-
fies the number of care processes that should be provided
for an individual as an outcome variable. In prior studies,
NQI was used as a proxy variable for comorbidity (as a
predictor) rather than as an outcome.40 This analysis
validates that it is reasonable to use NQI as a proxy for
disease burden.
There are several limitations to this study. First,
because this study of comorbidity was planned as a medi-
cal record abstraction, the GXI variable definitions were
customized to what is typically documented in hand-
written or dictated primary care records. Although the
GXI was not difficult to collect (12 minutes on average
per record), future refinement should occur within evolving
health systems that can routinely capture required data.
This study provides new insight into which comorbidities
should be candidates for systemwide automated data to
identify individuals requiring the most complex care. This
would also facilitate further validation with other mea-
sures of complexity important to healthcare systems such
as hospitalizations.
Second, the International Classification of Diseases
(ICD) codes used to score the HCC were not available,
so mapping of HCC variables to the chart-abstracted
information was relied on. A future study is needed to
develop an ICD version of the GXI for comparison with
the HCC, although ICD codes should not be the criterion stan-
dard for measuring geriatric comorbidity because ICD codes
do not capture important geriatric conditions such as falls.
A third potential limitation is that the ACOVE-2
study enrolled individuals with at least one geriatric condi-
tion, so the results of the current study might not be gener-
alizable to unselected older populations. Inclusion of
individuals with geriatric conditions increased the GXI for
all participants in the sample, therefore if an unselected
population with greater variation in GXI were re-enrolled,
it would be expected that association with greater differ-
ence in intensity of primary care would be found. Fourth,
the data were collected from 2002 to 2003, and practice
patterns may have evolved (e.g., with respect to number of
visits). Fifth, the sample was recruited from only two com-
munities in southern California, and participants were
nearly all white and had at least a high school education.
The influence of ethnic and socioeconomic diversity on the
predictive ability of this comorbidity index cannot be cap-
tured in this study. Sixth, this study focused on primary
care rather than all health care. Unlike the original
ACOVE-1 cohort,16 ACOVE-2 did not include the
ACOVE hospital and continuity of care QIs that contrib-
ute greatly to the overall complexity of medical care man-
aged by a medical home or healthcare system. How the
GXI relates to acute care measures of complexity (e.g.,
transitions and readmissions) requires further study. Last,
the number of potential ACOVE QIs doubled in 2007,41
mostly because of inclusion of new conditions; therefore,
NQI will increase even more for individuals with complex
needs as a result of the newer QI set.
In conclusion, detailed comorbidity and severity-of-
disease measures were used to capture the breadth of com-
plex ambulatory care due to geriatric, psychosocial, and
general medical conditions. The GXI can identify older
adults with complex care needs who require adequate time
and resources to provide them the ambulatory care that
they need. With refinement for use in an electronic health
record, the GXI could prospectively identify individuals
who need more attention from future medical homes.
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SUPPORTING INFORMATION
Additional Supporting Information may be found in the
online version of this article:
Appendix S1. Conditions, severity levels, prevalence,
and complexity of care weights used in the geriatric com-
plexity of care (GXI) score.
Appendix S2. A case series of comorbidity and com-
plexity in assessing care of vulnerable elders 2.
Please note: Wiley-Blackwell is not responsible for the
content, accuracy, errors, or functionality of any support-
ing materials supplied by the authors. Any queries (other
than missing material) should be directed to the corre-
sponding author for the article
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